Xontogeny is a life sciences accelerator focused on advancing early-stage biotechnology and biopharmaceutical companies from discovery through clinical proof-of-concept. Based in Boston, the firm partners with scientific founders and entrepreneurs to help build and de-risk innovative therapies targeting serious diseases.
Through a hands-on, company-building model, Xontogeny provides strategic guidance, operational expertise, and access to a network of experienced industry leaders, investors, and development resources. Their team works closely with portfolio companies to strengthen clinical development pathways and improve the likelihood of success in bringing new medicines to patients.
Xontogeny’s mission is to accelerate the development of transformative life science technologies by combining scientific innovation with experienced operational leadership to build high-impact healthcare companies.
